Home/Rarity Bioscience/Ulf Landegren, Professor

Ulf Landegren, Professor

Scientific Founder/Developer

Therapeutic Areas

Drug	Indication	Phase
superRCA® Oncology Assays	Cancer mutation detection (e.g., MRD, therapy monitoring)	RUO/Clinical LDT